Fight Colorectal Cancer’s Post

Our new research blog article sheds light on Colorectal Cancer: From Sequences to Solutions: Exploring Research & Treatment. More interesting insights on our March Blog: https://lnkd.in/d7i_YCxB If you have missed our earlier blogs click here to learn more: https://lnkd.in/dwazpNE8 #colorectalcancer , #nextgenerationsequencing sequencing, #Genomicinstability, #Genomicprofiling, #Exomesequencing, #singlecellsequencing, #10xchromium, #targetedtherapy , #precisionmedicine , #Immunotherapy, #Immunecheckpointinhibitors, #tumormicroenvironment

The discovery mentioned in the text is of great importance in the health sector, especially for the diagnosis and treatment of prostate cancer. These advances represent a significant step towards more accurate and less invasive diagnosis, technically improving outcomes for patients. https://lnkd.in/dX3HkCZr #prostatecancer #diagnosis

In this cohort study of a colorectal cancer screening program, sequential automated and personalized strategies each were linked to substantial increases in screening completion in all demographic groups. https://ja.ma/3Uj1fg0

🚨Clinicians and scientists in Singapore have unveiled crucial insights into how gastric #cancer spreads to the peritoneum, thanks to a landmark study published in Gastroenterology. Led by Associate Professor Raghav Sundar MBBS, PhD, this breakthrough study could lead to more effective and targeted treatments for patients battling this aggressive form of cancer. 💡🔬 Additionally, the #PIANO trial led by Professor Jimmy Soh shows that combining Pressurised Intra-Peritoneal Aerosol Chemotherapy #PIPAC with immunotherapy could revolutionize treatment outcomes. 🌟 Read More: https://lnkd.in/gd-C8aHx #CancerResearch #NUSMedicine #GastricCancer #MedicalBreakthrough #InspiringInnovators #ClinicalTrials

#PaperSpotlight: On May 20, 2024, researchers Gregory L. Guzik and Ankit Mangla from University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Western Reserve University School of Medicine, and Case Comprehensive Cancer Center published a new editorial paper in Oncoscience, entitled, “Primary hepatic angiosarcoma: Treatment options for a rare tumor.” “[...] PHA is a rare yet aggressive mesenchymal tumor of the liver, which requires a multi-disciplinary approach to achieve the best patient outcomes.” #PressRelease: https://lnkd.in/eN2eUhCY #cancerresearch #angiosarcoma #liver #immunotherapy #oncology #openaccess #openscience #peerreviewed #journal #meded #publishing #publication #spotlight

Diabetes and liver cancer: Study suggests new screening guidelines . A new study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don't meet current screening guidelines. #ScienceDailynews #InnovativeResearch #NextGenScience #ExploringFrontiers

A recent investigation revealed that in laboratory mice with prostate cancer, a substance derived from sandalwood oil demonstrated efficacy in delaying the initiation and progression of tumors, leading to cellular demise. Subsequent studies will investigate the potential of this extract for prostate cancer treatment in humans. #Mouse #OilExtract #ProstateCancer #Sandalwood #Healthcare #Medicine #Science #Scitke

The CAM model is ideal for personalized medicine, especially for PDAC. It supports human tumor tissues without immune rejection and allows easy monitoring. Its simplicity, low cost, and reproducibility make it excellent for studying tumors and testing therapies, bridging the gap between cell-based and animal assays. https://lnkd.in/g_PsZ_AT #pancreaticcancer #PDAC #metastasis #chorioallantoicmembrane #CAMmodel #PCR #drugtargeting #drugrelease #personalizedmedicine #oncology #cancertherapy

At the 2024 Great Debates & Updates in Hematologic Malignancies meeting, Joshua Richter, MD, Icahn School of Medicine at Mount Sinai explores the role of #MRD in multiple myeloma treatment, addressing whether it should be used to make clinical decisions. Learn more: https://lnkd.in/e8zsr8cY #GDUHem #GDU #MultipleMyeloma #Oncology #Oncologist #OncologyNews